Sort
16,300 grants matching “fatty liver disease”
Molecular Drivers of FABP-mediated Endocannabinoid Signaling for Appetite Regulation
$157,000Ruth E. Stark · City College Of New York · R16 · FY2023 · GM
Effects of choline on fetal growth and lipid accretion in gestational diabetes
$157,000Xinyin Jiang · Brooklyn College · SC2 · FY2017 · DK
Molecular Drivers of FABP-mediated Endocannabinoid Signaling for Appetite Regulation
$157,000Ruth E. Stark · City College Of New York · R16 · FY2024 · GM
Molecular Drivers of FABP-mediated Endocannabinoid Signaling for Appetite Regulation
$157,000Ruth E. Stark · City College Of New York · R16 · FY2025 · GM
Protective Effects of Amlexanox Against Atherosclerosis
$156,924Peng Zhao · University Of California, San Diego · K99 · FY2019 · HL
Protective Effects of Amlexanox Against Atherosclerosis
$156,924Peng Zhao · University Of California, San Diego · K99 · FY2018 · HL
Inflammatory regulation of lipid accumulation in skeletal muscle with obesity
$156,733Matthew W Hulver · Virginia Polytechnic Inst And St Univ · R56 · FY2007 · DK
Diabetes/obesity prevention in youth
$156,644Madhumita Sinha · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2023 · DK
SREBP-Mediated Lipid Regulation in the Intestine
$156,600Luke James Engelking · Ut Southwestern Medical Center · K08 · FY2017 · DK
SREBP-Mediated Lipid Regulation in the Intestine
$156,600Luke James Engelking · Ut Southwestern Medical Center · K08 · FY2018 · DK
Identification of RORg drug candidates for the treatment of NASH
$156,503Jim Zapf · Visionary Pharmaceuticals, Inc. · R43 · FY2017 · DK
Phosphodiesterase 4 mediated pathogenic mechanisms in alcohol associated liver disease
$156,422Leila Gobejishvili · University Of Louisville · R01 · FY2024 · AA
Phosphodiesterase 4 mediated pathogenic mechanisms in alcohol associated liver disease
$156,422Leila Gobejishvili · University Of Louisville · R01 · FY2023 · AA
Visceral Adiposity and Diabetes: Translating Form to Function Using Imaging
$156,384Ian Jason Neeland · Ut Southwestern Medical Center · K23 · FY2017 · DK
Visceral Adiposity and Diabetes: Translating Form to Function Using Imaging
$156,384Ian Jason Neeland · Ut Southwestern Medical Center · K23 · FY2019 · DK
Continuation of the Nonalcoholic Steatohepatitis Clinical Research Network
$156,309Norah A. Terrault · University Of California, San Francisco · U01 · FY2013 · DK
A molecular mechanism whereby metformin protects against liver cancer
$156,277Hua Xiao · Michigan State University · R21 · FY2015 · CA
Metabolic Actions of Omega-3 Fatty Acids on Inflammation
$156,200Michael Miller · University Of Maryland Baltimore · R21 · FY2012 · HL
Etiologic Studies of Diet and Cancer
$156,154Neal Freedman · Division Of Cancer Epidemiology And Genetics · ZIA · FY2020 · CA
Metabolic Effects of Valproate and Antipsychotic Therapy
$156,116Dan W Haupt · Washington University · K23 · FY2007 · MH
Changes in T cell metabolism during graft-versus-host disease
$156,108Craig Alan Byersdorfer · University Of Pittsburgh At Pittsburgh · K08 · FY2017 · HL
CVD in American Indians: Imaging and Cardiovascular Center
$156,001Richard B Devereux · Weill Medical Coll Of Cornell Univ · R01 · FY2017 · HL
CVD in American Indians: Imaging and Cardiovascular Center
$156,001Richard B Devereux · Weill Medical Coll Of Cornell Univ · R01 · FY2016 · HL
The treatment of Alcohol Liver Disease with Retinoid Beta Agonists
$156,000Steven Trasino · Hunter College · SC2 · FY2019 · GM
Developing tools for calcium imaging in ITPR2-linked liver pathogenesis
$156,000Gyorgy Hajnoczky · Thomas Jefferson University · R03 · FY2023 · TR